Skip to content

Clinical trials

Recruiting Overweight trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Recruiting Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20221
20241
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet3
Novo Nordisk A/S3
Amgen1
AstraZeneca1
Eatit AB1
Eli Lilly and Company1
Emma Svennberg1
Linkoeping University1
Sahlgrenska University Hospital1
Vastra Gotaland Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight14
Obesity13
Cardiovascular Diseases2
Hypertension2
Atherosclerosis1
Atrial Fibrillation1
Chronic Pain1
Congenital Abnormalities1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.